Your session is about to expire
← Back to Search
Smoking Cessation E-Visit for Quitting Smoking (INSPIRE Trial)
N/A
Recruiting
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights
INSPIRE Trial Summary
This trial will evaluate an online questionnaire to help people quit smoking, with potential to receive a prescription for a smoking cessation medication. Participants will complete questionnaires & provide breath samples over a 24 week period.
Who is the study for?
This trial is for adults who smoke at least 5 cigarettes daily, have been smoking regularly for over 6 months, and are not currently using any quit-smoking treatments. Participants must live where they can get mail, speak English, use or be willing to sign up for Epic's MyChart program, check their email daily, and own a smartphone compatible with the study's breath sample app.Check my eligibility
What is being tested?
The study is testing an online e-visit system designed to help people stop smoking in rural primary care settings. Some participants will receive this e-visit intervention while others will continue with usual care. The e-visit includes questions about smoking habits and may lead to a prescription for quitting aids but doesn't require taking medication.See study design
What are the potential side effects?
There might be no direct side effects from participating in the e-visits themselves; however, if participants choose to take prescribed cessation medications as a result of the e-visit recommendation, they could experience side effects associated with those specific drugs.
INSPIRE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reduction in Cigarettes Per Day
Smoking Cessation
INSPIRE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Smoking cessation electronic visit (e-visit)Experimental Treatment1 Intervention
This group will be sent 1) an invitation to complete an electronic visit (e-visit) focused on cigarette smoking and 2) an invitation to complete a follow-up e-visit one-month after the initial e-visit.
Group II: Treatment as usual (TAU)Active Control1 Intervention
This group will be provided information about the state quitline and about the importance of quitting smoking and it will be recommended that they contact their PCP to schedule a medical visit to discuss quitting smoking.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking cessation e-visit
2019
N/A
~60
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,394,327 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,924,046 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have started a smoking cessation treatment with FDA-approved medication in the last week.I have been smoking more than 5 cigarettes daily for the last 6 months.I am 18 years old or older.I am enrolled in or willing to enroll in Epic's MyChart program.I check my email daily and can access study materials and messages.
Research Study Groups:
This trial has the following groups:- Group 1: Smoking cessation electronic visit (e-visit)
- Group 2: Treatment as usual (TAU)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants being welcomed into this experiment?
"The research posted on clinicaltrials.gov indicates that this trial is not seeking participants at the moment. It was initially listed on February 28th 2023 and has not been updated since then; however, there are 155 other active trials which may be of interest to potential volunteers."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger